Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Dupuytren’s Disease Market Growth Performance Trended Historically, And What Lies Ahead?
The market size for Dupuytren’s disease has seen robust growth over the recent years. It is projected to escalate from $4.28 billion in 2024 to $4.51 billion in 2025, experiencing a compound annual growth rate (CAGR) of 5.3%. The significant growth in previous years can be linked to factors such as the increase in the elderly population, a rise in genetic predisposition, uptick in diabetes occurrence, a surge in alcohol consumption, and the increment in manual labor leading to recurring hand injuries.
A significant expansion is projected in the Dupuytren’s disease market size within the next several years, with an expected growth up to$5.62 billion by 2029 at a Compound Annual Growth Rate (CAGR) of 5.7%. This anticipated growth during the forecasted years is primarily influenced by factors such as amplified advancements in treatment techniques, enhanced awareness, earlier diagnosis, elevated healthcare expenditure, increased acceptance of minimally invasive approaches, and burgeoning research and development efforts. Major developments expected to shape the forecast period include progress in gene therapy, advancements in regenerative medicine and stem cell therapy, innovations in AI-powered diagnostic tools, advances in 3D printing for personalized orthotics, as well as breakthroughs in minimally invasive surgical methods.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21944&type=smp
What External and Internal Drivers Are Contributing to the Growth of theDupuytren’s Disease Market?
The growth of the dupuytren’s disease market is anticipated to be fueled by the increasing popularity of minimally invasive treatments. These medical procedures, which involve minor incisions or tissue damage, provide benefits such as pain alleviation and minimal scarring. Minimally invasive treatments are gaining favor as they offer a quicker recovery process involving less discomfort and a significantly decreased risk of complications, compared to traditional surgeries. For patients with Dupuytren’s disease, these treatments are efficiently relieving symptoms, improving hand functionality, lessening contracture, and ensuring an expedited and more pleasant recovery period. For example, a report published by the Royal Australasian College of Surgeons (RACS), an Australian government organization, in June 2023, stated that there was a 12% increase in procedures carried out using da Vinci platforms, skyrocketing from 17,852 in 2021 to 19,989 in 2022 in Australia. Consequently, the escalating demand for minimally invasive treatments is a primary factor propelling the expansion of the dupuytren’s disease market.
What Segment Types Define the Dupuytren’s Disease Market Structure?
The dupuytren’s diseasemarket covered in this report is segmented –
1) By Disease Type: Type I; Type II; Type III
2) By Treatment: Surgery; Radiation Therapy; Needle Aponeurotomy; Steroid Shot; Enzyme Injection; Occupational Therapy; Other Treatments
3) By Route of Administration: Oral; Parenteral; Other Routes Of Administration
4) By Diagnosis: Physical Examination; X-Ray; Other Diagnosis
5) By End-User: Hospitals; Clinics; Academic And Research Institute; Other End-Users
Subsegments:
1) By Type I: Classical Dupuytren’s Disease; Familial Dupuytren’s Disease
2) By Type II: Palmar Fasciitis; Ledderhose Disease
3) By Type III: Garrod’s Pads; Peyronie’s Disease
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=21944&type=smp
Which Geographic Areas Hold the Strongest Growth Potential in the Dupuytren’s Disease Market?
North America was the largest region in the dupuytren’s disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dupuytren’s disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Long-Term Trends Are Transforming the Competitive Landscape of the Dupuytren’s Disease Market?
Prominent businesses in the Dupuytren’s disease market are concentrating on clinical studies to create innovative, front-line, disease-modifying therapies. These clinical studies evaluate the protection, efficiency, and potential side effects of novel medical practices, drugs, or procedures in human subjects before they can be universally adopted. For example, in April 2023, Ventoux Biosciences, an American biopharmaceutical firm specialized in developing non-invasive treatments for Dupuytren’s diseases, released positive results from its pre-clinical trials for its fibrosis medication, specifically designed for Dupuytren’s contracture, a condition that affects nearly five percent of the U.S. populace. Ventoux’s primary candidate, VEN-201, is a repurposed commercially available drug that demonstrated success in reducing skin fibrosis in animal models. This significant breakthrough has led Ventoux to begin a funding round to progress the development of VEN-201.
View the full report here:
https://www.thebusinessresearchcompany.com/report/dupuytrens-disease-global-market-report
What Is the Definition of the Dupuytren’s Disease Market?
Dupuytren’s disease, also known as dupuytren’s contracture is a condition that affects the connective tissue (fascia) in the palm and fingers, causing thickening and tightening. The condition causes the fingers to bend toward the palm over time, making it difficult to straighten them or perform everyday tasks.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21944
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model